ACADL · rs3764913
Where this position leads
Condition: Blood Metabolite Levels
What the study found
Who was studied 214 European ancestry prostate cancer cases, 188 European ancestry controls; replicated in 489 European ancestry prostate cancer cases.
The effect The reported allele is T; the catalogue records no effect size ; p = 4 × 10−29.
Where it sits Chromosome 2, band 2q34 — in an intron of ACADL.
What ClinVar records
Classification
Benign; criteria provided, single submitter (1 of 4 stars, 1 submitter), last evaluated 2022-04-26.
ClinVar record 4684633 NM_001608.4(ACADL):c.603+11A>G
What this is ClinVar's aggregate record for this position (as of its 2026-10-19 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.
rs3764913 is a single position in the genome, in or near the ACADL gene. Published research associates it with metabolite levels. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
On MyGeneLog this position is linked to Blood Metabolite Levels. The research behind each link, and its sources, are set out on that condition page.
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
GWAS Catalog, Hum Mutat 2013, PMID:23281178. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.
Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.
Metabolite levels (rs3764913). MyGeneLog™. https://www.mygenelog.com/variants/rs3764913